deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03176472

Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

Sponsor: Regenacy Pharmaceuticals LLC

Conditions Painful Diabetic Peripheral Neuropathy
Interventions Placebo ricolinostat
Updated 13 times since 2017 Last updated: Sep 18, 2023 Started: Dec 7, 2020 Primary completion: Oct 31, 2022 Completion: Apr 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Painful Diabetic Peripheral Neuropathy and is currently completed. Regenacy Pharmaceuticals LLC leads this study, which shows 13 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~May 2020 · 12 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2022 · 16 months · monthly snapshot~Sep 2022 – ~Oct 2023 · 13 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Sep 2022 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. May 2021 — Sep 2022 [monthly]

    Recruiting PHASE2

▶ Show 8 earlier versions

  1. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  2. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  3. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. May 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  6. May 2019 — May 2020 [monthly]

    Not Yet Recruiting PHASE2

  7. Jun 2018 — May 2019 [monthly]

    Not Yet Recruiting PHASE2

  8. Jun 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Regenacy Pharmaceuticals LLC
Data source: Regenacy Pharmaceuticals LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anniston, United States , Austin, United States , Berlin, United States , Brooklyn, United States , Clearwater, United States , Evansville, United States , Greensboro, United States , Houston, United States , Huntington Beach, United States , Huntington Park, United States and 23 more locations